Stroke admissions and revascularization treatments in Denmark during COVID-19

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Stroke admissions and revascularization treatments in Denmark during COVID-19. / Drenck, Nicolas; Grundtvig, Josefine; Christensen, Thomas; Iversen, Helle Klingenberg; Kruuse, Christina; Truelsen, Thomas; Wienecke, Troels; Christensen, Hanne.

In: Acta Neurologica Scandinavica, Vol. 145, No. 2, 2022, p. 160-170.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Drenck, N, Grundtvig, J, Christensen, T, Iversen, HK, Kruuse, C, Truelsen, T, Wienecke, T & Christensen, H 2022, 'Stroke admissions and revascularization treatments in Denmark during COVID-19', Acta Neurologica Scandinavica, vol. 145, no. 2, pp. 160-170. https://doi.org/10.1111/ane.13535

APA

Drenck, N., Grundtvig, J., Christensen, T., Iversen, H. K., Kruuse, C., Truelsen, T., Wienecke, T., & Christensen, H. (2022). Stroke admissions and revascularization treatments in Denmark during COVID-19. Acta Neurologica Scandinavica, 145(2), 160-170. https://doi.org/10.1111/ane.13535

Vancouver

Drenck N, Grundtvig J, Christensen T, Iversen HK, Kruuse C, Truelsen T et al. Stroke admissions and revascularization treatments in Denmark during COVID-19. Acta Neurologica Scandinavica. 2022;145(2):160-170. https://doi.org/10.1111/ane.13535

Author

Drenck, Nicolas ; Grundtvig, Josefine ; Christensen, Thomas ; Iversen, Helle Klingenberg ; Kruuse, Christina ; Truelsen, Thomas ; Wienecke, Troels ; Christensen, Hanne. / Stroke admissions and revascularization treatments in Denmark during COVID-19. In: Acta Neurologica Scandinavica. 2022 ; Vol. 145, No. 2. pp. 160-170.

Bibtex

@article{d9f02ff73ce048dfb6f9db0c6b88ab3d,
title = "Stroke admissions and revascularization treatments in Denmark during COVID-19",
abstract = "Objective: The aim of this study was to assess the number of stroke-related admissions and acute treatments during the first two waves of COVID-19 and lockdowns in the Capital Region of Denmark and the Region of Zealand. Materials & Methods: The weekly numbers of admitted patients with stroke were retrieved from electronic patient records from January 2019 to February 2021 and analysed to reveal potential fluctuations in patient volumes during the pandemic. Results: A total of 23,688 patients were included, of whom 2049 patients were treated with tissue-type plasminogen activators (tPA) and 552 underwent endovascular thrombectomy (EVT). We found a transient decrease in the number of weekly admitted patients (pts/week) with all strokes (−9.8 pts/week, 95% CI: −19.4; −0.2, p =.046) and stroke mimics (−30.1 pts/week, 95% CI: −39.9; −20.3, p <.001) during the first lockdown compared to pre-COVID-19. The number of subarachnoid haemorrhage, intracerebral haemorrhage, and ischaemic stroke admissions showed insignificant declines. Analysing all COVID-19 periods collectively revealed increased volumes of ischaemic stroke (+6.2 pts/week, 95% CI: +1.6; +10.7, p =.009) compared to pre-COVID levels, while numbers of stroke mimics remained lower than pre-COVID. Weekly tPA and EVT treatments remained constant throughout the study period. Conclusions: Our results are comparable with other studies in finding reductions in stroke-related admissions early in the pandemic. This is the first study to report increased stroke volumes following the first wave of the pandemic. The mechanisms behind the observed drop and subsequent rise in strokes are unclear and warrant further investigation.",
keywords = "COVID-19, ischaemic stroke, pandemic, stroke, thrombectomy, thrombolysis",
author = "Nicolas Drenck and Josefine Grundtvig and Thomas Christensen and Iversen, {Helle Klingenberg} and Christina Kruuse and Thomas Truelsen and Troels Wienecke and Hanne Christensen",
note = "Publisher Copyright: {\textcopyright} 2021 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd",
year = "2022",
doi = "10.1111/ane.13535",
language = "English",
volume = "145",
pages = "160--170",
journal = "Acta Neurologica Scandinavica",
issn = "0001-6314",
publisher = "Wiley-Blackwell",
number = "2",

}

RIS

TY - JOUR

T1 - Stroke admissions and revascularization treatments in Denmark during COVID-19

AU - Drenck, Nicolas

AU - Grundtvig, Josefine

AU - Christensen, Thomas

AU - Iversen, Helle Klingenberg

AU - Kruuse, Christina

AU - Truelsen, Thomas

AU - Wienecke, Troels

AU - Christensen, Hanne

N1 - Publisher Copyright: © 2021 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd

PY - 2022

Y1 - 2022

N2 - Objective: The aim of this study was to assess the number of stroke-related admissions and acute treatments during the first two waves of COVID-19 and lockdowns in the Capital Region of Denmark and the Region of Zealand. Materials & Methods: The weekly numbers of admitted patients with stroke were retrieved from electronic patient records from January 2019 to February 2021 and analysed to reveal potential fluctuations in patient volumes during the pandemic. Results: A total of 23,688 patients were included, of whom 2049 patients were treated with tissue-type plasminogen activators (tPA) and 552 underwent endovascular thrombectomy (EVT). We found a transient decrease in the number of weekly admitted patients (pts/week) with all strokes (−9.8 pts/week, 95% CI: −19.4; −0.2, p =.046) and stroke mimics (−30.1 pts/week, 95% CI: −39.9; −20.3, p <.001) during the first lockdown compared to pre-COVID-19. The number of subarachnoid haemorrhage, intracerebral haemorrhage, and ischaemic stroke admissions showed insignificant declines. Analysing all COVID-19 periods collectively revealed increased volumes of ischaemic stroke (+6.2 pts/week, 95% CI: +1.6; +10.7, p =.009) compared to pre-COVID levels, while numbers of stroke mimics remained lower than pre-COVID. Weekly tPA and EVT treatments remained constant throughout the study period. Conclusions: Our results are comparable with other studies in finding reductions in stroke-related admissions early in the pandemic. This is the first study to report increased stroke volumes following the first wave of the pandemic. The mechanisms behind the observed drop and subsequent rise in strokes are unclear and warrant further investigation.

AB - Objective: The aim of this study was to assess the number of stroke-related admissions and acute treatments during the first two waves of COVID-19 and lockdowns in the Capital Region of Denmark and the Region of Zealand. Materials & Methods: The weekly numbers of admitted patients with stroke were retrieved from electronic patient records from January 2019 to February 2021 and analysed to reveal potential fluctuations in patient volumes during the pandemic. Results: A total of 23,688 patients were included, of whom 2049 patients were treated with tissue-type plasminogen activators (tPA) and 552 underwent endovascular thrombectomy (EVT). We found a transient decrease in the number of weekly admitted patients (pts/week) with all strokes (−9.8 pts/week, 95% CI: −19.4; −0.2, p =.046) and stroke mimics (−30.1 pts/week, 95% CI: −39.9; −20.3, p <.001) during the first lockdown compared to pre-COVID-19. The number of subarachnoid haemorrhage, intracerebral haemorrhage, and ischaemic stroke admissions showed insignificant declines. Analysing all COVID-19 periods collectively revealed increased volumes of ischaemic stroke (+6.2 pts/week, 95% CI: +1.6; +10.7, p =.009) compared to pre-COVID levels, while numbers of stroke mimics remained lower than pre-COVID. Weekly tPA and EVT treatments remained constant throughout the study period. Conclusions: Our results are comparable with other studies in finding reductions in stroke-related admissions early in the pandemic. This is the first study to report increased stroke volumes following the first wave of the pandemic. The mechanisms behind the observed drop and subsequent rise in strokes are unclear and warrant further investigation.

KW - COVID-19

KW - ischaemic stroke

KW - pandemic

KW - stroke

KW - thrombectomy

KW - thrombolysis

U2 - 10.1111/ane.13535

DO - 10.1111/ane.13535

M3 - Journal article

C2 - 34605006

AN - SCOPUS:85116095142

VL - 145

SP - 160

EP - 170

JO - Acta Neurologica Scandinavica

JF - Acta Neurologica Scandinavica

SN - 0001-6314

IS - 2

ER -

ID: 281649107